首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1729255

日本疫苗市场报告（按产品类型、治疗类型、技术、给药途径、患者类型、适应症、配销通路、最终用户和地区）2025-2033

Japan Vaccine Market Report by Product Type, Treatment Type, Technology, Route of Administration, Patient Type, Indication, Distribution Channel, End User, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024年日本疫苗市场规模达30亿美元。展望未来， IMARC Group预计到2033年市场规模将达到39亿美元，2025-2033年期间的成长率（CAGR）为2.88%。多种慢性病的盛行率不断上升、医疗保险覆盖范围不断扩大以及群众对疫苗接种重要性的认识不断提高是推动市场发展的一些关键因素。

疫苗是一种含有减毒或灭活形式的病原体或其成分的生物製剂。它可以刺激免疫系统并提供针对特定疾病的免疫力。它经过了严格的安全测试，以确保不会对接受者造成重大风险。它有多种形式，包括减毒活疫苗、灭活疫苗、次单位疫苗、mRNA 疫苗和病毒载体疫苗。在储存和运输过程中需要严格的温度控制以保持功效。它对于预防多种传染病非常有效，而且通常比治疗疾病更具成本效益。它通常用于婴儿和儿童，以保护他们免受麻疹、腮腺炎、德国麻疹和百日咳等疾病的侵害。

日本疫苗市场趋势：

日本老龄人口的不断增加是刺激预防与年龄相关的疾病的疫苗需求的主要因素之一。此外，多种慢性病的发生率不断上升，以及大众对疫苗接种重要性的认识不断提高，为该国的市场前景提供了良好的前景。此外，该国还拥有完善的分销网络，有助于确保疫苗覆盖全民。此外，日本越来越多地参与疫苗外交，这提升了其国际地位，并为疫苗製造商创造了机会，提高了生产和出口。此外，儿童疫苗接种计划的扩大，重点是确保儿童接种建议的疫苗，正在加强市场的成长。此外，对疫苗领域研发（R&D）工作的持续投资正在刺激市场成长。同时，与国际组织的合作日益增多，为人们取得各种疫苗提供了便利，并促进了市场成长。除此之外，强而有力的病患教育活动的发展正在传播有关疫苗益处的重要讯息，进一步提高疫苗接种率。此外，广泛的医疗保险覆盖确保了大多数人口能够负担得起疫苗。此外，日本作为医疗旅游目的地的崛起吸引了寻求疫苗接种等医疗服务的游客。此外，日本强大的流行病学监测系统有助于及时发现疾病爆发和疫苗接种需求，确保快速应对并满足疫苗需求。此外，日本国内疫苗生产能力的扩大确保了更自力更生和有弹性的供应链，减少了对进口的依赖。同时，该国管理当局正在实施各种激励措施并简化监管流程，以鼓励疫苗的开发和生产。这些措施降低了疫苗製造商的进入门槛，促进了市场创新和竞争。

日本疫苗市场区隔：

产品类型洞察：

多价疫苗
单价疫苗

治疗类型洞察：

预防疫苗
治疗性疫苗

技术洞察：

结合疫苗
灭活疫苗和次单位疫苗
减毒活疫苗
重组疫苗
类毒素疫苗
其他的

给药途径洞察：

肌肉注射和皮下注射
口服
其他的

患者类型洞察：

儿科
成人

指示见解：

细菌性疾病
- 脑膜炎球菌疾病
- 肺炎球菌疾病
- 白喉/破伤风/百日咳（DPT）
- 结核
- 流感嗜血桿菌（Hib）
- 伤寒
- 其他的
病毒性疾病
- 肝炎
- 流感
- 人类乳突病毒（HPV）
- 麻疹/腮腺炎/德国麻疹 (MMR)
- 轮状病毒
- 带状疱疹
- 水痘
- 日本脑炎
- 风疹
- 小儿麻痹
- 狂犬病
- 登革热
- 其他的

配销通路洞察：

医院药房
零售药局
机构销售
其他的

最终用户洞察：

医院
诊所
疫苗接种中心
学术和研究机构
其他的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

日本疫苗市场目前表现如何？未来几年将如何表现？
新冠疫情对日本疫苗市场有何影响？
日本疫苗市场依产品类型划分是怎样的？
日本疫苗市场依治疗类型如何划分？
日本疫苗市场依技术划分是怎样的？
日本疫苗市场依给药途径的分布如何？
日本疫苗市场依患者类型如何划分？
日本疫苗市场按适应症的分布是怎样的？
日本疫苗市场按配销通路的分布如何？
根据最终用户，日本疫苗市场的分布如何？
日本疫苗市场的价值链分为哪些阶段？
日本疫苗的关键驱动因素和挑战是什么？
日本疫苗市场的结构是怎么样的？主要参与者有哪些？
日本疫苗市场的竞争程度如何？

本报告回答的关键问题：

日本疫苗市场目前表现如何？未来几年将如何表现？
新冠疫情对日本疫苗市场有何影响？
日本疫苗市场依产品类型划分是怎样的？
日本疫苗市场依治疗类型如何划分？
日本疫苗市场依技术划分是怎样的？
日本疫苗市场依给药途径的分布如何？
日本疫苗市场依患者类型如何划分？
日本疫苗市场按适应症的分布是怎样的？
日本疫苗市场按配销通路的分布如何？
根据最终用户，日本疫苗市场的分布如何？
日本疫苗市场的价值链分为哪些阶段？
日本疫苗的关键驱动因素和挑战是什么？
日本疫苗市场的结构是怎么样的？主要参与者有哪些？
日本疫苗市场的竞争程度如何？

细菌性疾病
- 概述
- 市场区隔
  - 脑膜炎球菌疾病
  - 肺炎球菌疾病
  - 白喉/破伤风/百日咳（DPT）
  - 结核
  - 流感嗜血桿菌（Hib）
  - 伤寒
  - 其他的
病毒性疾病
- 概述
- 市场区隔
  - 肝炎
  - 流感
  - 人类乳突病毒（HPV）
  - 麻疹/腮腺炎/德国麻疹 (MMR)
  - 轮状病毒
  - 带状疱疹
  - 水痘
  - 日本脑炎
  - 风疹
  - 小儿麻痹
  - 狂犬病
  - 登革热
  - 其他的

第 12 章：日本疫苗市场 - 细分：按配销通路

医院药房
- 概述
零售药局
- 概述
机构销售
- 概述
其他的
- 概述

第 13 章：日本疫苗市场 - 细分：按最终用户

医院
- 概述
诊所
- 概述
疫苗接种中心
- 概述
学术和研究机构
- 概述
其他的

第 14 章：日本疫苗市场 - 竞争格局

概述
市场结构
市场参与者定位
最佳获胜策略
竞争仪錶板
公司评估象限

第 15 章：关键参与者简介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第十六章：日本疫苗市场-产业分析

驱动因素、限制因素和机会
- 概述
- 驱动程式
- 限制
- 机会
波特五力分析
- 概述
- 买家的议价能力
- 供应商的议价能力
- 竞争程度
- 新进入者的威胁
- 替代品的威胁
价值链分析

第 17 章：附录

简介目录

Product Code: SR112025A17199

Japan vaccine market size reached USD 3.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2033, exhibiting a growth rate (CAGR) of 2.88% during 2025-2033. The rising prevalence of several chronic diseases, increasing availability of extensive health insurance coverage, and the growing awareness among the masses about the importance of vaccination represent some of the key factors driving the market.

A vaccine is a biological preparation that contains weakened or inactivated forms of pathogens or their components. It is administered to stimulate the immune system and provide immunity against specific diseases. It is rigorously tested for safety to ensure it does not pose significant risks to recipients. It is available in various forms, which include live attenuated, inactivated, subunit, mRNA, and viral vector vaccines. It requires strict temperature control during storage and transportation to maintain efficacy. It is highly effective in preventing a wide range of infectious diseases and often more cost-effective than treating the diseases. It is routinely administered to infants and children to protect them from diseases like measles, mumps, rubella, and pertussis.

Japan Vaccine Market Trends:

The expanding aging population in Japan represents one of the primary factors catalyzing the demand for vaccines to protect against age-related diseases. Additionally, the rising prevalence of several chronic diseases and the growing awareness among the masses about the importance of vaccination are offering a favorable market outlook in the country. Along with this, the country has a well-established distribution network that aids in ensuring vaccines reach the entire population. Apart from this, the increasing participation of Japan in vaccine diplomacy initiatives is bolstering its international standing and creating opportunities for vaccine manufacturers, enhancing production and exports. Furthermore, the expansion of pediatric vaccination programs with a focus on ensuring children receive recommended vaccines is strengthening the growth of the market. Moreover, continuous investments in research and development (R&D) efforts in the field of vaccines are stimulating the market growth. Along with this, rising collaborations with international organizations are facilitating access to a wide range of vaccines and contributing to market growth. Apart from this, the introduction of robust patient education campaigns is disseminating vital information about the benefits of vaccines, further improving acceptance rates. In addition, the availability of extensive health insurance coverage is ensuring the affordability of vaccines for the majority of the population. In addition, the emergence of Japan as a healthcare tourism destination is attracting visitors seeking healthcare services, including vaccinations. Furthermore, the robust epidemiological surveillance systems in Japan facilitate the identification of disease outbreaks and vaccination needs promptly, ensuring a swift response and heightened vaccine demand. Moreover, the expansion of domestic vaccine manufacturing capacity in Japan is ensuring a more self-reliant and resilient supply chain, reducing dependence on imports. Along with this, governing authorities of the country are implementing various incentives and streamlining regulatory processes to encourage vaccine development and manufacturing. These initiatives reduce the barriers to entry for vaccine manufacturers, fostering innovation and competition in the market.

Japan Vaccine Market Segmentation:

Product Type Insights:

Multivalent Vaccine
Monovalent Vaccine

Treatment Type Insights:

Preventive Vaccine
Therapeutic Vaccine

Technology Insights:

Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
Toxoid Vaccines
Others

Route of Administration Insights:

Intramuscular and Subcutaneous Administration
Oral Administration
Others

Patient Type Insights:

Pediatric
Adult

Indication Insights:

Bacterial Diseases
- Meningococcal Disease
- Pneumococcal Disease
- Diphtheria/Tetanus/Pertussis (DPT)
- Tuberculosis
- Haemophilus Influenzae (Hib)
- Typhoid
- Others
Viral Diseases
- Hepatitis
- Influenza
- Human Papillomavirus (HPV)
- Measles/Mumps/Rubella (MMR)
- Rotavirus
- Herpes Zoster
- Varicella
- Japanese Encephalitis
- Rubella
- Polio
- Rabies
- Dengue
- Others

Distribution Channel Insights:

Hospital Pharmacies
Retail Pharmacies
Institutional Sales
Others

End User Insights:

Hospitals
Clinics
Vaccination Centers
Academic and Research Institutes
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan vaccine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan vaccine market?
What is the breakup of the Japan vaccine market on the basis of product type?
What is the breakup of the Japan vaccine market on the basis of treatment type?
What is the breakup of the Japan vaccine market on the basis of technology?
What is the breakup of the Japan vaccine market on the basis of route of administration?
What is the breakup of the Japan vaccine market on the basis of patient type?
What is the breakup of the Japan vaccine market on the basis of indication?
What is the breakup of the Japan vaccine market on the basis of distribution channel?
What is the breakup of the Japan vaccine market on the basis of end user?
What are the various stages in the value chain of the Japan vaccine market?
What are the key driving factors and challenges in the Japan vaccine?
What is the structure of the Japan vaccine market and who are the key players?
What is the degree of competition in the Japan vaccine market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Vaccine Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Vaccine Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Vaccine Market - Breakup by Product Type

6.1 Multivalent Vaccine
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Monovalent Vaccine
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Vaccine Market - Breakup by Treatment Type

7.1 Preventive Vaccine
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Therapeutic Vaccine
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Vaccine Market - Breakup by Technology

8.1 Conjugate Vaccines
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Inactivated and Subunit Vaccines
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Live Attenuated Vaccines
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Recombinant Vaccines
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Toxoid Vaccines
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2019-2024)
- 8.6.2 Market Forecast (2025-2033)

9 Japan Vaccine Market - Breakup by Route of Administration

9.1 Intramuscular and Subcutaneous Administration
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Oral Administration
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2019-2024)
- 9.3.2 Market Forecast (2025-2033)

10 Japan Vaccine Market - Breakup by Patient Type

10.1 Pediatric
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
10.2 Adult
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)

11 Japan Vaccine Market - Breakup by Indication

11.1 Bacterial Diseases
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2019-2024)
- 11.1.3 Market Segmentation
  - 11.1.3.1 Meningococcal Disease
  - 11.1.3.2 Pneumococcal Disease
  - 11.1.3.3 Diphtheria/Tetanus/Pertussis (DPT)
  - 11.1.3.4 Tuberculosis
  - 11.1.3.5 Haemophilus Influenzae (Hib)
  - 11.1.3.6 Typhoid
  - 11.1.3.7 Others
- 11.1.4 Market Forecast (2025-2033)
11.2 Viral Diseases
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2019-2024)
- 11.2.3 Market Segmentation
  - 11.2.3.1 Hepatitis
  - 11.2.3.2 Influenza
  - 11.2.3.3 Human Papillomavirus (HPV)
  - 11.2.3.4 Measles/Mumps/Rubella (MMR)
  - 11.2.3.5 Rotavirus
  - 11.2.3.6 Herpes Zoster
  - 11.2.3.7 Varicella
  - 11.2.3.8 Japanese Encephalitis
  - 11.2.3.9 Rubella
  - 11.2.3.10 Polio
  - 11.2.3.11 Rabies
  - 11.2.3.12 Dengue
  - 11.2.3.13 Others
- 11.2.4 Market Forecast (2025-2033)

12 Japan Vaccine Market - Breakup by Distribution Channel

12.1 Hospital Pharmacies
- 12.1.1 Overview
- 12.1.2 Historical and Current Market Trends (2019-2024)
- 12.1.3 Market Forecast (2025-2033)
12.2 Retail Pharmacies
- 12.2.1 Overview
- 12.2.2 Historical and Current Market Trends (2019-2024)
- 12.2.3 Market Forecast (2025-2033)
12.3 Institutional Sale
- 12.3.1 Overview
- 12.3.2 Historical and Current Market Trends (2019-2024)
- 12.3.3 Market Forecast (2025-2033)
12.4 Others
- 12.4.1 Overview
- 12.4.2 Historical and Current Market Trends (2019-2024)
- 12.4.3 Market Forecast (2025-2033)

13 Japan Vaccine Market - Breakup by End User

13.1 Hospitals
- 13.1.1 Overview
- 13.1.2 Historical and Current Market Trends (2019-2024)
- 13.1.3 Market Forecast (2025-2033)
13.2 Clinics
- 13.2.1 Overview
- 13.2.2 Historical and Current Market Trends (2019-2024)
- 13.2.3 Market Forecast (2025-2033)
13.3 Vaccination Centers
- 13.3.1 Overview
- 13.3.2 Historical and Current Market Trends (2019-2024)
- 13.3.3 Market Forecast (2025-2033)
13.4 Academic and Research Institutes
- 13.4.1 Overview
- 13.4.2 Historical and Current Market Trends (2019-2024)
- 13.4.3 Market Forecast (2025-2033)
13.5 Others
- 13.5.1 Historical and Current Market Trends (2019-2024)
- 13.5.2 Market Forecast (2025-2033)

14 Japan Vaccine Market - Competitive Landscape

14.1 Overview
14.2 Market Structure
14.3 Market Player Positioning
14.4 Top Winning Strategies
14.5 Competitive Dashboard
14.6 Company Evaluation Quadrant

15 Profiles of Key Players

15.1 Company A
- 15.1.1 Business Overview
- 15.1.2 Product Portfolio
- 15.1.3 Business Strategies
- 15.1.4 SWOT Analysis
- 15.1.5 Major News and Events
15.2 Company B
- 15.2.1 Business Overview
- 15.2.2 Product Portfolio
- 15.2.3 Business Strategies
- 15.2.4 SWOT Analysis
- 15.2.5 Major News and Events
15.3 Company C
- 15.3.1 Business Overview
- 15.3.2 Product Portfolio
- 15.3.3 Business Strategies
- 15.3.4 SWOT Analysis
- 15.3.5 Major News and Events
15.4 Company D
- 15.4.1 Business Overview
- 15.4.2 Product Portfolio
- 15.4.3 Business Strategies
- 15.4.4 SWOT Analysis
- 15.4.5 Major News and Events
15.5 Company E
- 15.5.1 Business Overview
- 15.5.2 Product Portfolio
- 15.5.3 Business Strategies
- 15.5.4 SWOT Analysis
- 15.5.5 Major News and Events

16 Japan Vaccine Market - Industry Analysis

16.1 Drivers, Restraints and Opportunities
- 16.1.1 Overview
- 16.1.2 Drivers
- 16.1.3 Restraints
- 16.1.4 Opportunities
16.2 Porters Five Forces Analysis
- 16.2.1 Overview
- 16.2.2 Bargaining Power of Buyers
- 16.2.3 Bargaining Power of Suppliers
- 16.2.4 Degree of Competition
- 16.2.5 Threat of New Entrants
- 16.2.6 Threat of Substitutes
16.3 Value Chain Analysis

17 Appendix

02-2729-4219

+886-2-2729-4219

License/价格

日本疫苗市场报告（按产品类型、治疗类型、技术、给药途径、患者类型、适应症、配销通路、最终用户和地区）2025-2033

Japan Vaccine Market Report by Product Type, Treatment Type, Technology, Route of Administration, Patient Type, Indication, Distribution Channel, End User, and Region 2025-2033

日本疫苗市场趋势：

日本疫苗市场区隔：

产品类型洞察：

治疗类型洞察：

技术洞察：

给药途径洞察：

患者类型洞察：

指示见解：

配销通路洞察：

最终用户洞察：

竞争格局：

本报告回答的关键问题：

本报告回答的关键问题：

目录

第一章：前言

第二章：范围与方法

第三章：执行摘要

第四章：日本疫苗市场-简介

第五章：日本疫苗市场格局

第六章：日本疫苗市场-细分：依产品类型

第七章：日本疫苗市场-分类：依治疗类型

第 8 章：日本疫苗市场 - 按技术细分

第九章：日本疫苗市场-分类：依给药途径

第 10 章：日本疫苗市场 - 细分：依病患类型

第 11 章：日本疫苗市场 - 细分：按适应症

第 12 章：日本疫苗市场 - 细分：按配销通路

第 13 章：日本疫苗市场 - 细分：按最终用户

第 14 章：日本疫苗市场 - 竞争格局

第 15 章：关键参与者简介

第十六章：日本疫苗市场-产业分析

第 17 章：附录

Japan Vaccine Market Trends:

Japan Vaccine Market Segmentation:

Product Type Insights:

Treatment Type Insights:

Technology Insights:

Route of Administration Insights:

Patient Type Insights:

Indication Insights:

Distribution Channel Insights:

End User Insights:

Competitive Landscape:

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Japan Vaccine Market - Introduction

5 Japan Vaccine Market Landscape

6 Japan Vaccine Market - Breakup by Product Type

7 Japan Vaccine Market - Breakup by Treatment Type

8 Japan Vaccine Market - Breakup by Technology

9 Japan Vaccine Market - Breakup by Route of Administration

10 Japan Vaccine Market - Breakup by Patient Type

11 Japan Vaccine Market - Breakup by Indication

12 Japan Vaccine Market - Breakup by Distribution Channel

13 Japan Vaccine Market - Breakup by End User

14 Japan Vaccine Market - Competitive Landscape

15 Profiles of Key Players

16 Japan Vaccine Market - Industry Analysis

17 Appendix